Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants-Reference-Cited by-同舟云学术

Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants

Published:2020-04-18 Issue:2 Volume:181 Page:445-453
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Bernstein-Molho Rinat,Friedman Eitan,Kedar Inbal,Laitman Yael,Allweis Tanir M.,Gal-Yam Einav Nili,Feldman Hagit Baris,Grinshpun Albert,Halpern Naama,Hartmajer Shulamit,Kadouri Luna,Katz Lior H.,Kaufman Bella,Laish Ido,Levanon Keren,Philipsborn Shira Litz,Ludman Mark,Moran Gal,Peretz Tamar,Reinstein Eyal,Levi Gili Reznick,Safra Tamar,Shkedi Shiri,Vinkler Chana,Levy Zohar,Goldberg Yael

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-020-05633-2.pdf

Reference33 articles.

1. Foulkes WD (2008) Inherited susceptibility to common cancers. N Engl J Med 359:2143–2153

2. Easton DF, Pharoah PDP, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL et al (2015) Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372:2243–2257

3. Whitworth J, Skytte A-B, Sunde L, Lim DH, Arends MJ, Happerfield L et al (2016) Multilocus inherited neoplasia alleles syndrome: a case series and review. JAMA Oncol 2:373–379

4. Domchek SM, Bradbury A, Garber JE, Offit K, Robson ME (2013) Multiplex genetic testing for cancer susceptibility: out on the high wire without a net? J Clin Oncol 31:1267–1270

5. Hampel H, Bennett RL, Buchanan A, Pearlman R, Wiesner GL (2015) A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. Genet Med 17:70–87

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted genotyping for recurring variants in cancer susceptibility genes in non‐Ashkenazi Jewish patients with breast cancer diagnosed ≥50 years;Cancer;2024-04-17

2. The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy;Breast Cancer Research and Treatment;2024-02-12

3. The Diagnostic Yield and Implications of Targeted Founder Pathogenic Variant Testing in an Israeli Cohort;Cancers;2023-12-24

4. Characterization of patients with a diagnosis of breast cancer and melanoma: genetic susceptibility or increased surveillance?;European Journal of Cancer Prevention;2023-03-13

5. Proteomic signature for detection of high‐grade ovarian cancer in germline BRCA mutation carriers;International Journal of Cancer;2022-10-23